Finland· FI-REL-REL47371
Zinbryta
A daclizumab product containing daclizumab, registered in Finland by Biogen Idec Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Daclizumab is registered in 3 of 19 countries.
Countries holding a registration under ATC L04AC01 (daclizumab), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Daclizumab · ATC L04AC01
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Daclizumab
- Manufacturer
- Biogen Idec Limited
- Country
- Finland (FI)
- ATC code
- L04AC01
- ATC class
- Daclizumab
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daclizumab in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/feab406d-a467-4f3a-8336-afe3e316944c GET /v1/drugs/feab406d-a467-4f3a-8336-afe3e316944c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "injektioneste, liuos, esitäytetty ruisku",
"route": null,
"ddd_unit": "mg",
"strength": "150 mg",
"atc_label": "daklitsumabi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/16/1107/001-02",
"fimea_rel_id": "REL47371",
"authorised_at": "2016-07-01"
}See everything about daclizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.